MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011)

Clinical trial NCT00420420 · COMPLETED

Trial details

NCT number: NCT00420420
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2006-11-01
Primary completion: 2008-08-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.